Consensus EPS · Q2 2026
$2.11
Consensus revenue · Q2 2026
$905.4M
Analysts
9
Expected report
Jul 29, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $893.2M | $905.4M | $910.3M |
| EPS | $2.07 | $2.11 | $2.14 |
| EBITDA | $244.6M | $247.2M | $249.7M |
| EBIT | $202.6M | $204.7M | $206.8M |
| Net income | $153.9M | $156.8M | $158.3M |
- Revenue$905.4M
- EPS$2.11
- EBITDA$247.2M
- EBIT$204.7M
- Net income$156.8M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $886.9M | $845.6M | +4.9% | $2.00 | $1.77 | +13.1% |
- Q1 2026+4.9%+13.1%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for IDEX (IEX) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 2 analysts.
- Low
- $214.00
- Consensus
- $247.00
- Median
- $250.00
- High
- $261.00
- Current
- $223.16
- Upside
- +10.7%
Upside calculated vs most recent trading price of $223.16.
Analyst ratings
Consensus: Hold — based on 29 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jun 2, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 30, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 30, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Apr 30, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 14, 2026 | Stifel | maintain | Buy | Buy |
| Mar 27, 2026 | BMO Capital | maintain | Market Perform | Market Perform |
| Feb 6, 2026 | Argus Research | upgrade | Hold | Buy |
| Feb 5, 2026 | TD Cowen | maintain | Buy | Buy |
| Feb 5, 2026 | RBC Capital | maintain | Outperform | Outperform |
- Jul 16, 2026RBC CapitalOutperform
- Jun 2, 2026OppenheimerOutperform
- Apr 30, 2026TD CowenBuy
- Apr 30, 2026RBC CapitalOutperform
- Apr 30, 2026CitigroupBuy
- Apr 14, 2026StifelBuy
- Mar 27, 2026BMO CapitalMarket Perform
- Feb 6, 2026Argus ResearchBuy
- Feb 5, 2026TD CowenBuy
- Feb 5, 2026RBC CapitalOutperform
Frequently asked questions
IDEX (IEX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.95% TTM
- Dividend Profile1.29% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.